chlorambucil has been researched along with Movement Disorders in 2 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A new autosomal recessive mouse mutation characterized by deafness and circling behavior was recovered during mutagenesis experiments with chlorambucil (CHL)." | 3.69 | A high-resolution genetic map around waltzer on mouse chromosome 10 and identification of a new allele of waltzer. ( Bryda, EC; Flaherty, L; Ling, H, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryda, EC | 1 |
| Ling, H | 1 |
| Flaherty, L | 1 |
| Van Zanducke, M | 1 |
| Dehaene, I | 1 |
2 other studies available for chlorambucil and Movement Disorders
| Article | Year |
|---|---|
A high-resolution genetic map around waltzer on mouse chromosome 10 and identification of a new allele of waltzer.
Topics: Alleles; Animals; Chlorambucil; Chromosome Mapping; Crosses, Genetic; Deafness; Female; Male; Mice; | 1997 |
A "cortico-basal degeneration"-like syndrome as first sign of progressive multifocal leukoencephalopathy.
Topics: Aged; Antineoplastic Agents, Alkylating; Apraxias; Chlorambucil; Cognition Disorders; Combined Modal | 2000 |